Dermatology · Williamsville, NY
NPI
1598764433
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
8421 Sheridan Dr
Williamsville, NY, 14221
Phone (716) 810-0610
Groups this clinician bills Medicare through
Medicare paid, 2024
$73K
2,502 services
Medicare patients, 2024
686
Average age 76
Drug cost, 2024
$1.1M
3,315 prescriptions
Company payments, 2025
$3,650
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David J Altman was code 17003 (destruction skin lesion), 1,180 times for 221 patients. In total David J Altman billed 2,502 services in 13 codes, and Medicare paid $73K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-07-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,180 | 221 | $4.27 | $5,043 |
| 99213 Office E&M - Established | Office | 544 | 480 | $56.65 | $31K |
| 17000 Destruction Skin Lesion | Office | 355 | 312 | $39.70 | $14K |
| 99212 Office E&M - Established | Office | 216 | 182 | $34.59 | $7,471 |
| 11102 Skin Biopsy | Office | 65 | 64 | $69.90 | $4,544 |
| 17004 Destruction Skin Lesion | Office | 49 | 41 | $106.53 | $5,220 |
| 99203 Office E&M - New | Office | 29 | 29 | $68.08 | $1,974 |
| 99202 Office E&M - New | Office | 25 | 25 | $48.86 | $1,222 |
| 11103 Skin Biopsy | Office | 22 | 16 | $35.97 | $791 |
By year: 2022 $94K for 3,140 services; 2023 $65K for 2,504 services; 2024 $73K for 2,502 services.
Medicare prescription drug claims, 2024
In 2024, the drug David J Altman prescribed most often to Medicare patients was Triamcinolone Acetonide, with 529 prescriptions and refills. In total David J Altman wrote 3,315 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 529 | 573 | 367 | $6,756 |
| Ketoconazole Generic | 452 | 476 | 238 | $11K |
| Doxycycline Hyclate Generic | 213 | 248 | 53 | $3,241 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 166 | 178 | 102 | $2,445 |
| Metronidazole Generic | 154 | 172 | 86 | $11K |
| Fluocinonide Generic | 153 | 162 | 97 | $4,958 |
| Valacyclovir Valacyclovir Hcl | 152 | 176 | 54 | $3,208 |
| Clobetasol Propionate Generic | 104 | 127 | 56 | $4,017 |
| Betamethasone Dipropionate Generic | 100 | 103 | 71 | $3,139 |
| Dupixent Pen Dupilumab | 89 | 96 | 11 | $359K |
| Clindamycin Phosphate Generic | 87 | 89 | 45 | $2,151 |
| Pimecrolimus Generic | 71 | 79 | 58 | $20K |
| Alclometasone Dipropionate Generic | 70 | 76 | 45 | $3,589 |
| Methotrexate Methotrexate Sodium | 63 | 93 | 12 | $1,150 |
| Ciclopirox Generic | 47 | 47 | 21 | $2,090 |
Brand drugs: 303 claims; generic drugs: 3,012 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David J Altman $3,650 ($3,650 in general payments such as food, travel and fees) from 18 companies. The largest payer was UCB, Inc. with $550.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 32 | $550 |
| Janssen Biotech, Inc. JNJ | 25 | $531 |
| Abbvie Inc. ABBV | 42 | $508 |
| Regeneron Healthcare Solutions, Inc. REGN | 17 | $337 |
| Novartis Pharmaceuticals Corporation NVS | 31 | $294 |
| Genzyme Corporation SNY | 13 | $223 |
| Galderma Laboratories, L.P. GALD.SW | 19 | $218 |
| E.R. Squibb & Sons, L.L.C. BMY | 15 | $195 |
| Amgen Inc. AMGN | 8 | $146 |
| Lilly USA, LLC LLY | 5 | $131 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.